Home Tools
Log in
Cart

Search Result

Search Results for " mgcd265 "

3

Compounds

Cat No. Product Name Synonyms Targets
T15384 Glesatinib MGCD265 c-Met/HGFR
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
T15383 Glesatinib hydrochloride MGCD265 hydrochloride c-Met/HGFR
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO. Glesatinib hydrochloride is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
T6351 MGCD-265 analog MGCD-265,Glesatinib Apoptosis , VEGFR , c-Met/HGFR
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
TargetMol